Dr. Brian Wispelwey, MD

Dr. Wispelwey practices at UVA University Medical Center in Charlottesville, Virginia.

Dr. Wispelwey's NPI, 1245375245, was assigned on February 20, 2007. Dr. Wispelwey graduated from Rutgers New Jersey Medical School in 1982. Dr. Wispelwey holds Virginia license 0101044106.

Dr. Wispelwey's primary practice is UVA University Medical Center, at 1215 Lee St, Charlottesville, VA 22908 in Charlottesville City. The practice phone is (434) 760-3439.

Dr. Wispelwey's primary practice is UVA University Medical Center in Charlottesville, Virginia. Dr. Wispelwey is also affiliated with University Medical Center. The medical group on file is UVA Physicians Group. Dmand AI also links Dr. Wispelwey to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wispelwey practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Wispelwey's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Wispelwey is licensed in Virginia.

CMS data shows 510 Medicare services from Dr. Wispelwey across 5 procedure codes in 2024, for 157 Medicare patients. Medicare paid $36,913 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 157 Medicare patients who saw Dr. Wispelwey in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 3.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Wispelwey's median patient age at 59, with 46% women.

In 2024, Dr. Wispelwey wrote 31 Medicare Part D claims. 84% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $396 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Wispelwey for performance year 2024, reported as part of a group. Dr. Wispelwey accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Wispelwey from 1 drug or device company in 2016. Education make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $59.

Dr. Wispelwey graduated from Rutgers New Jersey Medical School in 1982.